Revolutionary Neurotechnology Startup Brings Innovation to Tripura

Codonmind Nexus, a pioneering neurotechnology startup in Tripura led by Dr. Saikat Kar, challenges traditional innovation hubs by developing brain-computer interface devices and research tools. With strategic support from the Tripura Startup Policy 2024 and a visionary dual-focus strategy, the region is positioned for a biotech renaissance.

In Agartala, a city more familiar with its tea gardens and vibrant handicrafts, a remarkable transformation is underway. Codonmind Nexus Private Limited, Northeast India's first neurotechnology startup, is actively developing cutting-edge brain-computer interface devices and innovative neurological research tools poised to rival major players nationwide. These advancements come amid projections that value India's neurotechnology market at USD 164 million by 2030.

Behind this transformation is Dr. Saikat Kar, a 31-year-old neuroscientist whose inspiring journey defies traditional career expectations. Having started in a humble ₹2,000 room in Agartala, Dr. Kar's career included esteemed positions at Harvard Medical School and the University of Edinburgh before deciding to bring his expertise back home. Contrary to the norm of Indian startups settling in cities like Bangalore or Pune, Codonmind Nexus is thriving in Agartala with a strategy targeting both healthcare and consumer wellness markets. Tripura's recent 66% growth in startup recognitions over five years is bolstered by the Tripura Startup Policy 2024, offering crucial support to budding entrepreneurs, as highlighted by Jeya Ragul Geshan B, IFS, at the Tamil Nadu Global Startup Summit 2025.

Dr. Kar's personal story—from being the son of a low-income government employee and achieving notable academic success despite financial limitations—adds depth to his ambitious venture. His acceptance into prestigious programs at Harvard and Edinburgh made him the first in his family to pursue advanced STEM education abroad, underscoring a narrative of resilience and self-directed learning. Returning to Agartala, he rejected more comfortable international opportunities to build a neurotechnology firm and establish Dr. SK's Biology, a platform that simplifies complex neuroscience concepts. With domestic demand for brain-computer interfaces driven by increasing mental health awareness, Codonmind Nexus fills a critical gap in the market. The startup benefits from Tripura's supportive ecosystem, overcoming typical deep-tech hurdles like high development costs and regulatory challenges. Recognizing the significance of 'brain circulation' over 'brain drain,' Dr. Kar reflects on his journey: "I've taken many risks in my life. Maybe I will succeed, maybe not, but I will keep taking these risks," highlighting his commitment to fostering local innovation.

(With inputs from agencies.)